These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 9678683)
1. Blood-brain barrier permeability of the demented elderly as studied by cerebrospinal fluid-serum albumin ratio. Wada H Intern Med; 1998 Jun; 37(6):509-13. PubMed ID: 9678683 [TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal Fluid/Plasma Albumin Ratio as a Biomarker for Blood-Brain Barrier Impairment Across Neurodegenerative Dementias. Musaeus CS; Gleerup HS; Høgh P; Waldemar G; Hasselbalch SG; Simonsen AH J Alzheimers Dis; 2020; 75(2):429-436. PubMed ID: 32280104 [TBL] [Abstract][Full Text] [Related]
3. Albumin and immunoglobulin in plasma and cerebrospinal fluid, and blood-cerebrospinal fluid barrier function in patients with dementia of Alzheimer type and multi-infarct dementia. Alafuzoff I; Adolfsson R; Bucht G; Winblad B J Neurol Sci; 1983; 60(3):465-72. PubMed ID: 6631444 [TBL] [Abstract][Full Text] [Related]
4. A population study on blood-brain barrier function in 85-year-olds: relation to Alzheimer's disease and vascular dementia. Skoog I; Wallin A; Fredman P; Hesse C; Aevarsson O; Karlsson I; Gottfries CG; Blennow K Neurology; 1998 Apr; 50(4):966-71. PubMed ID: 9566380 [TBL] [Abstract][Full Text] [Related]
5. CSF monoamine metabolites in old age dementias. Parnetti L; Gaiti A; Reboldi GP; Santucci C; Mecocci P; Brunetti M; Cadini D; Senin U Mol Chem Neuropathol; 1992; 16(1-2):143-57. PubMed ID: 1381590 [TBL] [Abstract][Full Text] [Related]
6. Acute phase reactant alpha 1-antichymotrypsin is increased in cerebrospinal fluid and serum of patients with probable Alzheimer disease. Licastro F; Parnetti L; Morini MC; Davis LJ; Cucinotta D; Gaiti A; Senin U Alzheimer Dis Assoc Disord; 1995; 9(2):112-8. PubMed ID: 7662323 [TBL] [Abstract][Full Text] [Related]
7. Blood-brain-barrier in a geriatric population: barrier function in degenerative and vascular dementias. Mecocci P; Parnetti L; Reboldi GP; Santucci C; Gaiti A; Ferri C; Gernini I; Romagnoli M; Cadini D; Senin U Acta Neurol Scand; 1991 Sep; 84(3):210-3. PubMed ID: 1950463 [TBL] [Abstract][Full Text] [Related]
8. [Concentrations of multiple neurochemicals in the cerebrospinal fluid of patients with senile dementia and the relationship to alpha 1-antichymotrypsin]. Wada H; Iijima S; Mizoguchi T; Mashige F; Orimo H Nihon Ronen Igakkai Zasshi; 1993 Jan; 30(1):46-53. PubMed ID: 8474228 [TBL] [Abstract][Full Text] [Related]
9. Evidence of blood-cerebrospinal fluid-barrier impairment in a subgroup of patients with dementia of the Alzheimer type and major depression: a possible indicator for immunoactivation. Hampel H; Müller-Spahn F; Berger C; Haberl A; Ackenheil M; Hock C Dementia; 1995; 6(6):348-54. PubMed ID: 8563789 [TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal fluid/serum albumin quotient (Q-Alb) is not increased in Alzheimer's disease compared to neurological disease controls: a retrospective study on 276 patients. Giacopuzzi Grigoli E; Solca F; Milone I; Aiello EN; Dubini A; Ratti A; Torresani E; Poletti B; Ticozzi N; Ciusani E; Silani V; Verde F Neurol Sci; 2023 Feb; 44(2):709-713. PubMed ID: 36441343 [TBL] [Abstract][Full Text] [Related]
11. Serum and cerebrospinal fluid proteins and the blood-brain barrier in Alzheimer's disease and multi-infarct dementia. Elovaara I; Palo J; Erkinjuntti T; Sulkava R Eur Neurol; 1987; 26(4):229-34. PubMed ID: 3595662 [TBL] [Abstract][Full Text] [Related]
12. [Serum alpha 1-antichymotrypsin in senile dementia]. Nagao T; Hamamoto M; Hagiwara M; Kanda A; Ichiseki H; Miyazaki T; Isse K; Tanaka K; Ogura M; Tsushima T Nihon Ronen Igakkai Zasshi; 1992 Oct; 29(10):778-82. PubMed ID: 1460783 [TBL] [Abstract][Full Text] [Related]
13. Alpha 1-antichymotrypsin as a possible biochemical marker for Alzheimer-type dementia. Matsubara E; Hirai S; Amari M; Shoji M; Yamaguchi H; Okamoto K; Ishiguro K; Harigaya Y; Wakabayashi K Ann Neurol; 1990 Oct; 28(4):561-7. PubMed ID: 2147546 [TBL] [Abstract][Full Text] [Related]
14. The integrity of the blood-brain barrier in Alzheimer's type and multi-infarct dementia evaluated by the study of albumin and IgG in serum and cerebrospinal fluid. Leonardi A; Gandolfo C; Caponnetto C; Arata L; Vecchia R J Neurol Sci; 1985 Feb; 67(2):253-61. PubMed ID: 3981221 [TBL] [Abstract][Full Text] [Related]
15. Plasma and cerebrospinal fluid alpha1-antichymotrypsin levels in Alzheimer's disease: correlation with cognitive impairment. DeKosky ST; Ikonomovic MD; Wang X; Farlow M; Wisniewski S; Lopez OL; Becker JT; Saxton J; Klunk WE; Sweet R; Kaufer DI; Kamboh MI Ann Neurol; 2003 Jan; 53(1):81-90. PubMed ID: 12509851 [TBL] [Abstract][Full Text] [Related]
16. CSF/serum folate gradient: physiology and determinants with special reference to dementia. Hagnelius NO; Wahlund LO; Nilsson TK Dement Geriatr Cogn Disord; 2008; 25(6):516-23. PubMed ID: 18463447 [TBL] [Abstract][Full Text] [Related]
17. Amino acid concentrations in cerebrospinal fluid and serum in Alzheimer's disease and vascular dementia. Martinez M; Frank A; Diez-Tejedor E; Hernanz A J Neural Transm Park Dis Dement Sect; 1993; 6(1):1-9. PubMed ID: 8216758 [TBL] [Abstract][Full Text] [Related]
18. Altered blood-brain-barrier function in Alzheimer's disease? Mattila KM; Pirttilä T; Blennow K; Wallin A; Viitanen M; Frey H Acta Neurol Scand; 1994 Mar; 89(3):192-8. PubMed ID: 8030400 [TBL] [Abstract][Full Text] [Related]
19. Alpha 1-antichymotrypsin and IL-1 beta are not increased in CSF or serum in Alzheimer's disease. Pirttila T; Mehta PD; Frey H; Wisniewski HM Neurobiol Aging; 1994; 15(3):313-7. PubMed ID: 7936055 [TBL] [Abstract][Full Text] [Related]
20. Integrity of the blood-CSF barrier in dementia of Alzheimer type: CSF/serum ratios of albumin and IgG. Frölich L; Kornhuber J; Ihl R; Fritze J; Maurer K; Riederer P Eur Arch Psychiatry Clin Neurosci; 1991; 240(6):363-6. PubMed ID: 1831668 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]